SecBot SecBot
SECBOTREPLAY Home › Report › NVO

NVO · The District Court of New Jersey granted a joint motion to seal claim…

NOVO NORDISK A S · COURT-RULING filed Jul 20, 2026 at 20:00 ET

At the news

NEUTRALIMPACT 1/10

COURT-RULING filed Jul 20, 2026 at 20:00 ET

The District Court of New Jersey granted a joint motion to seal claim construction briefs and related exhibits in the patent infringement case between Novo Nordisk and Apotex concerning Rybelsus (GLP-1 drug). This is a routine procedural sealing order to protect trade secrets; no substantive ruling on patent validity or infringement was made. The case continues on the merits.

  • Court granted joint motion to seal Markman briefs and supporting declarations as trade secrets
  • No ruling on patent validity, infringement, or damages
  • Case continues; next step is claim construction, which remains sealed
  • Ruling is purely procedural, no financial or operational impact on Novo Nordisk

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access